Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| 10-K | 10-K | 10-K |
Revenues: |
United States | 583.0 | 533.5 | 443.7 |
EMEA & APAC | 1,465.2 | 1,423.9 | 1,182.7 |
Americas | 1,128.3 | 1,004.2 | 767.4 |
Total revenues | 2,593.5 | 2,428.1 | 1,950.1 |
Revenue growth [+] | 6.8% | 24.5% | |
United States | 9.3% | 20.2% | |
EMEA & APAC | 2.9% | 20.4% | |
Americas | 12.4% | 30.9% | |
Cost of goods sold | 1,708.0 | 1,590.1 | 1,267.6 |
Gross profit | 885.5 | 838.0 | 682.5 |
Gross margin | 34.1% | 34.5% | 35.0% |
Selling, general and administrative | 533.4 | 512.8 | 458.7 |
Other operating expenses | 9.1 | 11.2 | |
EBITDA [+] | 409.0 | 389.9 | 300.4 |
EBITDA growth | 4.9% | 29.8% | |
EBITDA margin | 15.8% | 16.1% | 15.4% |
Depreciation | 30.4 | 33.8 | 34.8 |
EBITA | 378.6 | 356.1 | 265.6 |
EBITA margin | 14.6% | 14.7% | 13.6% |
Amortization of intangibles | 35.6 | 42.1 | 41.8 |
EBIT [+] | 343.0 | 314.0 | 223.8 |
EBIT growth | 9.3% | 40.3% | |
EBIT margin | 13.2% | 12.9% | 11.5% |
Non-recurring items [+] | 14.0 | 7.7 | 21.6 |
Pension curtailments and settlements | -9.1 | -11.2 | |
Interest income | | 0.0 | 1.0 |
Interest income | | 0.0 | 1.0 |
Other income (expense), net | -28.8 | 12.8 | 2.7 |
Pre-tax income | 300.3 | 319.1 | 205.8 |
Income taxes | 69.2 | 80.4 | 46.0 |
Tax rate | 23.0% | 25.2% | 22.3% |
Minority interest | 4.3 | 3.6 | 2.5 |
Earnings from continuing ops | 226.8 | 235.1 | 157.4 |
Earnings from discontinued ops | -3.1 | | |
Net income | 223.7 | 235.1 | 157.4 |
Net margin | 8.6% | 9.7% | 8.1% |
|
Basic EPS [+] | $3.78 | $3.92 | $2.62 |
Growth | -3.6% | 49.4% | |
Diluted EPS [+] | $3.77 | $3.92 | $2.62 |
Growth | -3.7% | 49.4% | |
|
Dividends per share | $0.10 | | |
|
Shares outstanding (basic) [+] | 60.1 | 60.0 | 60.0 |
Growth | 0.0% | 0.0% | |
Shares outstanding (diluted) [+] | 60.2 | 60.0 | 60.0 |
Growth | 0.2% | 0.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|